If you are not happy with the results below please do another search
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, has joined the Coalition for Epidemic Preparedness Innovations (CEPI) Central Lab Network (CLN). The company says the strategic partnership represents a significant milestone in its commitment to global health security and its dedication to fostering collaboration and innovation in epidemic preparedness and response.
PrecisionLife, a leading techbio company driving precision medicine into complex chronic diseases, and Nanopharmaceutics, a clinicalstage pharmaceutical development company, have established a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system (CNS) assets.
OGT, a Sysmex Group company and leading global provider of clinical research and diagnostic solutions, has formed a new commercial partnership with Applied Spectral Imaging (ASI), a global leader in advanced biomedical imaging with a comprehensive product portfolio for karyotyping, H&E, IHC and FISH analysis. The agreement will grant OGT rights to market ASI’s proprietary […]
The European Laboratory Research & Innovation Group (ELRIG) has appointed Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.
Danish biotech Tetra Pharm Technologies announced promising results from a pre-clinical in vitro trial of its pain-relieving drug – TPT0301 – using a novel drug delivery technology. It was compared against more commonly used formulations for drug delivery in the oral cavity.
LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and […]
Antibodies against Epstein-Barr virus (EBV), a common virus that most people acquire early in life, are linked to multiple sclerosis (MS). This is shown in a study from the Karolinska Institutet, where technology from the biotech company Neogap Therapeutics has been used to map immune cells reactive to EBV and autoantigens related to MS.
SpaceMarkers, a new machine learning software developed by researchers at the Johns Hopkins Convergence Institute and the Johns Hopkins Kimmel Cancer Center, can identify molecular interactions among distinct types of cells in and around a tumour.
When it was launched in April 2003, the Human Genome Project helped revolutionize biomedical research by providing scientists a reference map that allowed them to analyze DNA sequences for genetic clues to the origins of a host of diseases.
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The partnership will enable Exothera to be the first CDMO in the world to offer this off-the-shelf process for the continuous production of RNA as a service. Continuous manufacturing of RNA can provide significant advantages in […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
